XML 12 R4.htm IDEA: XBRL DOCUMENT v3.23.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Net Sales $ 19,668 $ 16,124
Cost of Sales 17,069 16,910
Gross Profit (Loss) 2,599 (786)
Research and Product Development 278 1,567
Selling and Marketing 498 455
General and Administrative 3,250 3,818
Operating Loss (1,427) (6,626)
Other (Expense) Income    
Realized Gain on Investments 0 4
Interest Expense (387) (540)
Interest Income 64 0
Total Other Expense (323) (536)
Net Loss $ (1,750) $ (7,162)
Basic Net Loss per Share (in dollars per share) $ (0.10) $ (0.84)
Diluted Net Loss per Share (in dollars per share) $ (0.10) $ (0.84)
Basic Weighted Average Shares Outstanding (in shares) 18,359,940 8,544,225
Diluted Weighted Average Shares Outstanding (in shares) 18,359,940 8,544,225